Nykode Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Nykode Therapeutics's estimated annual revenue is currently $26.4M per year.
- Nykode Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Nykode Therapeutics has 170 Employees.
- Nykode Therapeutics grew their employee count by -22% last year.
Nykode Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | CTO | Reveal Email/Phone |
3 | Executive Assistant to Chief Technology Officer and to Chief R&D Officer | Reveal Email/Phone |
4 | Head Laboratory and EHS | Reveal Email/Phone |
5 | VP, Head Business Development | Reveal Email/Phone |
6 | VP, Head HR | Reveal Email/Phone |
7 | Chief Medical Officer | Reveal Email/Phone |
8 | Associate Director Head In Vivo Pharmacology | Reveal Email/Phone |
9 | Chief Financial Officer | Reveal Email/Phone |
10 | Director Technology and CMC | Reveal Email/Phone |
Nykode Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.1M | 7 | -36% | N/A | N/A |
#2 | $10.4M | 67 | 29% | N/A | N/A |
#3 | $8.5M | 55 | 2% | N/A | N/A |
#4 | $9.3M | 60 | -5% | N/A | N/A |
#5 | $8.4M | 54 | 54% | N/A | N/A |
#6 | $3.7M | 24 | -67% | N/A | N/A |
#7 | $3.7M | 24 | 0% | N/A | N/A |
#8 | $17.5M | 113 | 15% | N/A | N/A |
#9 | $26.4M | 170 | -22% | N/A | N/A |
#10 | $20M | 129 | 29% | N/A | N/A |
What Is Nykode Therapeutics?
We are a leading technology platform that unlocks unlimited possibilities for the future of medicine through our intelligent modular design and tailored hyper targeting.
keywords:N/AN/A
Total Funding
170
Number of Employees
$26.4M
Revenue (est)
-22%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $39.5M | 171 | -14% | N/A |
#2 | $20.8M | 171 | -6% | N/A |
#3 | $24.1M | 172 | 37% | N/A |
#4 | $62.1M | 172 | 31% | N/A |
#5 | $34.5M | 180 | 30% | N/A |